Tag
AI accelerates drug discovery by predicting candidates and reducing costs, but success depends on high-quality data and integration with lab systems to close the data loop and validate predictions.
o11, an AI agent for enterprise apps, launches specifically for the life sciences sector, targeting pharmaceutical and life science companies. The product is backed by prominent investors including Y Combinator, Accel, and OpenAI.
Amgen, a major pharmaceutical company, shares how it leverages GPT-5 in its operations. The case study highlights enterprise adoption of advanced AI models in the biotech/pharma sector.